The angiotensin II type 2 receptor in cardiovascular disease.
about
Angiotensin II, NADPH oxidase, and redox signaling in the vasculatureModulation of glucose metabolism by the renin-angiotensin-aldosterone systemMolecular Imaging of Vulnerable Atherosclerotic Plaques in Animal Models.Metabolic actions of angiotensin II and insulin: a microvascular endothelial balancing actMechanisms of Ghrelin anti-heart failure: inhibition of Ang II-induced cardiomyocyte apoptosis by down-regulating AT1R expressionLong-term systemic angiotensin II type 1 receptor blockade regulates mRNA expression of dorsomedial medulla renin-angiotensin system componentsCardamonin inhibits angiotensin II-induced vascular smooth muscle cell proliferation and migration by downregulating p38 MAPK, Akt, and ERK phosphorylation.High molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodelingSTRUCTURAL CHARACTERISTICS AND ANTIHYPERTENSIVE EFFECTS OF ANGIOTENSIN-I-CONVERTING ENZYME INHIBITORY PEPTIDES IN THE RENIN-ANGIOTENSIN AND KALLIKREIN KININ SYSTEMS.From gene to protein-experimental and clinical studies of ACE2 in blood pressure control and arterial hypertensionAngiotensin Ⅱ Activates MCP-1 and Induces Cardiac Hypertrophy and Dysfunction via Toll-like Receptor 4.Grape-derived polyphenols improve aging-related endothelial dysfunction in rat mesenteric artery: role of oxidative stress and the angiotensin system.Angiotensin II receptors and drug discovery in cardiovascular disease.Activation of central angiotensin type 2 receptors by compound 21 improves arterial baroreflex sensitivity in rats with heart failure.Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.Angiotensin II potentiates adrenergic and muscarinic modulation of guinea pig intracardiac neuronsPGC-1α limits angiotensin II-induced rat vascular smooth muscle cells proliferation via attenuating NOX1-mediated generation of reactive oxygen speciesInternational Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation.Cell signaling of angiotensin II on vascular tone: novel mechanisms.Potential role of renin-angiotensin system blockade for preventing myocardial ischemia/reperfusion injury and remodeling after myocardial infarction.The neurohormonal network in the RAAS can bend before breaking.Angiotensin II receptor antagonists in acute coronary syndromes.Oxidative stress-mediated effects of angiotensin II in the cardiovascular systemNeuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Update on the role of angiotensin in the pathophysiology of coronary atherothrombosis.Future drug discovery in renin-angiotensin-aldosterone system intervention.Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.Conditional expression of the type 2 angiotensin II receptor in mesenchymal stem cells inhibits neointimal formation after arterial injury.Angiotensin II receptor type 1 blockade decreases CTGF/CCN2-mediated damage and fibrosis in normal and dystrophic skeletal muscles.Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors.The angiotensin receptor blocker losartan reduces coronary arteriole remodeling in type 2 diabetic mice.Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis.Targeting the angiotensin II type 2 receptor (AT2R) in colorectal liver metastases.Activation of upregulated angiotensin II type 2 receptors decreases carotid pulse pressure in rats with suprarenal abdominal aortic coarctation.Effects of acute angiotensin II on ischemia reperfusion injury following myocardial infarction.Association between angiotensin II receptor type 1 A1166C polymorphism and chronic kidney disease.Angiotensin, transforming growth factor β and aortic dilatation in Marfan syndrome: Of mice and humans.Role of Lipotoxicity and Contribution of the Renin-Angiotensin System in the Development of Polycystic Ovary Syndrome.Chronic administration of the angiotensin type 2 receptor agonist C21 improves insulin sensitivity in C57BL/6 mice
P2860
Q26998758-4DE85133-F44E-47C6-B267-DF993C44D0A9Q27026157-6642438C-B742-487A-BCD5-1BED9DE2C86AQ28070313-83F844E8-0C38-4635-9B20-98549E242F5EQ28390079-49EB3816-E7DC-416C-BC77-759292A1A6AFQ28567598-760E4050-D6E0-4FD2-A0DA-5F39C7FAF20FQ28742760-9B468B6C-773B-40D1-99F3-98A109B82689Q29347161-2F925AA0-8F2F-4DDD-9E30-1ED1793CCF39Q31161236-260AA7CD-BF8C-412D-B7BF-102410B7E309Q33732962-B7A20E1C-ECAA-43EF-8887-5A87B5AC8856Q33795353-23B8A7C0-3AF3-4691-90EC-09775DBC3856Q33902466-ABE48DC2-8CA8-44C8-8338-51D8735FA834Q34182189-3442FDB8-087C-49CF-8EF0-807DA4D31D29Q34496676-520CBFB8-E0EF-4D83-956C-956BBF2E9E3FQ34500044-A0B55917-D1F1-434D-98B9-FF60FE2AB7B8Q34543485-9304D8D0-5167-47C0-AB80-92B51F323846Q35543367-00FD89C8-F55C-498A-9183-BEB7772D384BQ36185160-197440B8-70CB-4831-ADBE-004BFF571F61Q36241932-EEFE184C-2C9C-48A2-BB8C-FC5FCFBC8955Q37619867-97FD6A2B-BC18-4869-B43F-48BB4BFCEC78Q37832995-56DBE699-1C6A-4239-A856-B6419CD75CAFQ37862927-5042E739-7014-4351-BB87-3F5647ABE5DFQ38005037-8B0014A7-3DCA-46F7-826E-9695D66D0FDFQ38167346-B3F6F685-F340-43B3-9FC7-AA9A2FCAFFDDQ38192646-3BA798EF-5F51-46F1-8F95-6C6BCD960268Q38217456-1FA06F9F-DDF0-44A4-9C26-58C8C0C7EED5Q38317550-FDC3A682-DA20-4802-A553-F9805D70EC60Q38679303-5721F937-5069-481F-860A-9A6BF081925AQ38879747-7682B64D-56D4-4C63-A0AC-0C18024873E6Q38966432-03F6BF17-8645-41DC-82FC-CEB692E59469Q39529950-97887B3B-01E3-419E-BECA-22AE38881601Q40239566-3EA61540-FCB6-4F6A-9068-3A85A92CC62CQ40777113-E883C161-0151-4768-ABC1-1C7DFC4FFB6AQ41652967-1BEB5B73-3A2F-42BD-A07C-6D8F76C661D2Q41894216-F3269501-3E88-4C47-85BF-31B550EA53ABQ48200496-8B7319D4-22FF-4D3D-99AE-93DFEB49B64CQ50455651-CAD0C40B-A05E-45DC-8A70-572285560EF8Q55044234-BF94E875-B005-4192-83DD-8EEB4066F989Q55266983-2B21549B-CA0C-4DD7-92A3-F26392F2A5A8Q55403020-BBAD8599-2A59-4EA0-B523-340A613FBE70Q58699775-7D8A214E-0D1F-44DC-97F1-2E812BC48AB9
P2860
The angiotensin II type 2 receptor in cardiovascular disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The angiotensin II type 2 receptor in cardiovascular disease.
@en
The angiotensin II type 2 receptor in cardiovascular disease.
@nl
type
label
The angiotensin II type 2 receptor in cardiovascular disease.
@en
The angiotensin II type 2 receptor in cardiovascular disease.
@nl
prefLabel
The angiotensin II type 2 receptor in cardiovascular disease.
@en
The angiotensin II type 2 receptor in cardiovascular disease.
@nl
P2860
P356
P1476
The angiotensin II type 2 receptor in cardiovascular disease.
@en
P2093
Catherine A Lemarié
Ernesto L Schiffrin
P2860
P356
10.1177/1470320309347785
P577
2009-10-27T00:00:00Z